Joint research on personalized cancer immunotherapy using regenerated T cells derived from iPS cells
Joint research on personalized cancer immunotherapy using regenerated T cells derived from iPS cells
The first study of the “Rare Disease Research and Development Program based on patient-centered principle” that connects researchers with rare diseases and intractable disease patients has been completed.
Originally three-month plan has been significantly reduced to one month. – Patient Participation to “Study of Specific Immune Conditions of Autoimmune Diseases”